http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018052825-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c55239e53f96f13e16dfc76479188d32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
filingDate 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e02214a90020bd09820ecaa4ccdd202d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_866fdd09dc26c28d8bdbc8495d97de47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc8602343fc9542d8e266d764bf434d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87324ff2068b398b17269109f8b7699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c00f39dbc69e9fc99dd82e475c1e27
publicationDate 2018-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2018052825-A
titleOfInvention Hydroxyapatite sol cell proliferation disorder therapeutic agent
abstract PROBLEM TO BE SOLVED: To provide a therapeutic agent for cell proliferation disorder with few side effects and a method for producing the same. [MEANS FOR SOLVING PROBLEMS] A therapeutic agent for cell proliferation disorder comprising hydroxyapatite sol having an average crystallite size in a minor axis and a major axis direction of 3 nm to 50 nm as an active ingredient. (1) calcium hydroxide, (2) phosphoric acid or a salt of phosphoric acid, and (3) a step of obtaining a hydroxyapatite sol by reacting carbon dioxide gas or carbonate; Using the hydroxyapatite sol obtained in the above step, obtaining a therapeutic agent for cell proliferation disorder, Method for producing therapeutic agent for cell proliferation disorder [selection figure] None
priorityDate 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015155392-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009298666-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093208
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447730362

Total number of triples: 39.